If you have had three urine infections this year, you have probably had three courses of antibiotics, three conversations that ended with “drink more water,” and no conversation at all about why it keeps happening.
There is a reason it keeps happening, and there is a treatment recommended in a urology guideline for exactly this situation. A surprising number of women never hear about it.
What the guideline actually says
The American Urological Association, the Canadian Urological Association, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction publish a joint guideline on recurrent uncomplicated urinary tract infections in women. One of its recommendations is that clinicians should offer vaginal estrogen therapy to peri- and postmenopausal women with recurrent UTIs to reduce the risk of future infections.
Two words there are worth sitting with. “Should offer” is not a hedge — in guideline language it carries real weight. And “reduce the risk of future infections” is a prevention claim, not a treatment-of-the-current-infection claim. This is not what you take when you have burning today. It is what changes how often you get burning at all.
Why estrogen has anything to do with your bladder
The connection surprises people, because the words “vaginal estrogen” and “urinary tract infection” do not sound like they belong in the same sentence. They do, for two reasons.
The first is anatomy. The lower urinary tract and the vagina develop from the same embryonic tissue and share dense estrogen receptors. When estrogen falls at menopause, the lining of the urethra and bladder neck thins along with the vaginal lining. That is one defense weakened.
The second is the microbiome, and it is the bigger factor. Before menopause, estrogen keeps glycogen high in the vaginal epithelium. Lactobacilli feed on that glycogen and produce lactic acid, holding vaginal pH around 4. That acidity is hostile to E. coli, which causes the large majority of urinary tract infections.
After menopause, glycogen falls. Lactobacilli decline. The pH drifts up toward 6 or 7. Gut bacteria that were previously held back now colonize the area around the urethra comfortably — and from there it is a very short trip into the bladder.
So the pattern you are stuck in is not about hygiene, not about wiping technique, and not about how much water you drink. It is a change in the barrier.
What the evidence looks like
Randomized trials of vaginal estrogen in postmenopausal women with recurrent UTIs have shown meaningful reductions in infection rates compared with placebo, alongside the expected changes in vaginal pH and the return of lactobacilli.
The effect sizes vary between studies, as they do in any body of literature, and the studies differ in product and dose. But the direction is consistent, and the mechanism is understood rather than inferred — you can watch the pH fall and the flora shift. That combination is what moved this into guideline territory.
Compare that with what most women are offered. Continuous low-dose antibiotic prophylaxis works while you take it, then the benefit fades after you stop, and in the meantime you have driven resistance and disturbed your gut and vaginal flora. Cranberry products have some supportive trial data but vary widely in product and dose. D-mannose fared poorly in a well-conducted UK primary care randomized trial. None of these address the barrier.
What taking it actually involves
It is a low dose placed where the problem is. A cream with an applicator, a small vaginal insert, or a ring you replace every three months. Most regimens start nightly for about two weeks and then drop to twice a week, or in the case of the ring, a replacement four times a year.
Serum estradiol on standard low doses generally stays within the postmenopausal range, because so little is absorbed. That is the whole point of local therapy and it is why the risk conversation here is different from the risk conversation about systemic hormone therapy.
In late 2025 the FDA updated labeling on estrogen products and removed the class-wide boxed warning, including from low-dose vaginal products. Many clinicians had argued for years that applying warnings derived from systemic therapy trials to a low-dose local product was misleading women away from an effective treatment. The label changed; your individual history is still reviewed before anything is prescribed.
Give it time, and plan the overlap
Vaginal estrogen is not fast. The tissue takes about 12 weeks to fully respond, and most women notice something by 4 to 8 weeks.
That lag matters practically. If you are getting an infection every six weeks, starting estrogen alone and waiting hopefully is not a plan. We often overlap with a short course of antibiotic prophylaxis or post-coital prophylaxis at the start, then taper the antibiotic once the tissue has had time to change. The point is to get you covered through the gap, not to keep you on antibiotics indefinitely.
And this is maintenance, not a course. If you stop, the tissue reverts and the infections tend to come back. Most women stay on twice-weekly dosing.
Where it fits in a real workup
Vaginal estrogen is the backbone of prevention for postmenopausal recurrent UTI, but it is not the entire workup, and any clinic that hands it to you without asking anything else is cutting corners.
We confirm infections by culture, because a meaningful share of episodes that feel like infection are not, and treating those with antibiotics is all risk and no benefit. We measure whether your bladder empties, because retained urine sustains the cycle regardless of what your tissue looks like. We examine for prolapse. We look for the things that would change the answer.
Then we build a plan you can actually follow, including what to do when an infection does happen — because with a good prevention plan they become less frequent, not impossible.
If you take one thing from this
Repeat urinary tract infections after menopause are not bad luck, and they are not a hygiene failure. They have a cause, that cause is treatable, and treating it is what a urology guideline recommends.
If you have had two infections in six months or three in a year, that is the threshold. It is worth asking about.